Dr. Vani Konda, MD

Claim this profile

Baylor Scott & White Research Institute

Studies Esophageal Adenocarcinoma
Studies Esophageal Cancer
2 reported clinical trials
2 drugs studied

Affiliated Hospitals

Image of trial facility.

Baylor Scott & White Research Institute

Image of trial facility.

Baylor University Medical Center

Clinical Trials Vani Konda, MD is currently running

Image of trial facility.

Endoscopic Therapy vs Surveillance

for Barrett's Esophagus

The purpose of this study is to learn the best approach to treating patients with known or suspected Barrett's esophagus by comparing endoscopic surveillance to endoscopic eradication therapy. To diagnose and manage Barrett's esophagus and low-grade dysplasia, doctors commonly use procedures called endoscopic surveillance and endoscopic eradication therapy. Endoscopic surveillance is a type of procedure where a physician will run a tube with a light and a camera on the end of it down the patients throat and remove a small piece of tissue. The piece of tissue, called a biopsy, is about the size of the tip of a ball-point pen and is checked for abnormal cells and cancer cells. Endoscopic eradication therapy is a kind of surgery which is performed to destroy the precancerous cells at the bottom of the esophagus, so that healthy cells can grow in their place. It involves procedures to either remove precancerous tissue or burn it. These procedures can have side effects, so it is not certain whether risking those side effects is worth the benefit people get from the treatments. While both of these procedures are widely accepted approaches to managing the condition, there is not enough research to show if one is better than the other. Barrett's esophagus and low-grade dysplasia does not always worsen to high-grade dysplasia and/or cancer. In fact, it usually does not. So, if a patient's dysplasia is not worsening, doctors would rather not put patients at risk unnecessarily. On the other hand, endoscopic eradication therapy could possibly prevent the worsening of low-grade dysplasia into high-grade dysplasia or cancer (esophageal adenocarcinoma) in some patients. Researchers believe that the results of this study will help doctors choose the safest and most effective procedure for their patients with Barrett's esophagus and low-grade dysplasia. This is a multicenter study involving several academic, community and private hospitals around the United States. Up to 530 participants will be randomized. This study will also include a prospective observational cohort study of up to 150 Barrett's esophagus and low grade dysplasia patients who decline randomization in the randomized control trial but undergo endoscopic surveillance (Cohort 1) or endoscopic eradication therapy (Cohort 2), and are willing to provide longitudinal observational data.

Recruiting

1 award

N/A

Image of trial facility.

Sponge Capsule Diagnosis

for Esophageal Cancer

This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.

Recruiting

1 award

N/A

3 criteria

More about Vani Konda, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Vani Konda, MD has experience with

  • Sponge Capsule
  • Endoscopic Eradication Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Vani Konda, MD specialize in?

Is Vani Konda, MD currently recruiting for clinical trials?

Are there any treatments that Vani Konda, MD has studied deeply?

What is the best way to schedule an appointment with Vani Konda, MD?

What is the office address of Vani Konda, MD?

Is there any support for travel costs?